NSEFraud/Default/Arrest20h ago · 15 Sept 2026, 06:35 pm

Fraud/Default/Arrest

Mangalam Drugs And Organics Limited · MANGALAM

✦ AI Summary▼ NegativeDebt Restruc.

Mangalam Drugs And Organics Limited has informed the Exchange about default on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern6/10
Regulatory Risk9/10
Balance Sheet Risk8/10
Liquidity Impact4/10
Market Sentiment1/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mangalam Drugs And Organics Limited has informed the Exchange about Fraud/Default/Arrest

Attachments (1)

📄

MANGALAM_15092026183449_SE27.pdf

pdf

Download →
View document text
Mangalam Drugs and Organics Limited a— FANCALAM Regd. Office : Rupam Building, 3rd Floor, 239 P. D'Mello Road, Near G. P. 0. Mumbai - 400 001 h___d& @ 91-22-62616200 / 6300 / 8787 @ 91-22-62619090 o CIN : L24230MH1972PLC116413 vo REF: MDOL/CS-SE/2026-27/027 September 15", 2026 Listing Department Listing Department BSE Ltd National Stock Exchange of India 1 Floor, New Trade Wing, Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, 5™ Floor, Dalal Street, Fort, Plot No. C-1, Block G, Mumbai - 400 001 Bandra - Kurla Complex, Bandra(E), Mumbai — 400 051 Scrip Code: 532637 Symbol: MANGALAM Subject: Disclosure under Regulation 30, Part A of Schedule I of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 of default on bank loan account Dear Sir/Madam, This is with reference to Regulation 30. Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 whereby a Listed Entity is required to make disclosure to stock exchange(s) Events which shall be disclosed without any application of the guidelines for materiality as specified in sub-regulation (4) of regulation (30) Part A (6) Default by a Listed Entity non-payment of the interest or principal amount in full on the date when the debt has become due and payable. Explanation 1: In case of revolving facilities like cash credit, an entity would be considered to be in ‘default’ if the outstanding balance remains continuously in excess of the sanctioned limit or drawing power, whichever is lower, for more than thirty days. In view of the said provision, Mangalam Drugs and Organics Limited (the Company) is making subsequent intimation declaring that the Company has defaulted on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days, as per the regulations of your exchange. As on date, the data is given below: Sr.No | Loan Account Name of Bank Amount Overdue | Date of start of Number - Cash Rs. In Lacs as on | Default Credit A/c. No. 14/09/2026 1 60383561246 Bank of Maharashtra 951.19 17/10/2025 2 04170500000243 Bank of Baroda 606.08 20/10/2025 We are also making arrangements to pay the overdue amount as soon as possible Kindly take the above and attachment provided by management on your records. Thanking You, Yours Faithfully, For Mangalam Drugs & Organics Limited Govardhan M. Dhoot Managing Director DIN: 01240086 Factory : at Vapi (Gujarat) India @ contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com wffy Mangalam Drugs and Organics Limited —4 MANGALAM Regd. Office : R ®u 91p -a 2m 2 B -u 6i 2ld 6i 1n 6g, 2 03 0rd / F 6l 3oo 0r 0, /2 3 89 7 8P. 7 D @’' M 9e 1l -lo 2 2R -o 6a 2d 6, 1N 9e 0a 9r 0 G #. CP. I N0 . : M Lu 2m 4b 23a 0i M - H 4 10 90 7 20 P01 L. C 116413 WH cD orE edS iteN D 15/09/2026 The Company Secretary Mangalam Drugs and Organics Ltd. Mumbai. Subject : Disclosure of subsequent default on bank loan account Dear Sir/Madam, T Lh ti ds hl aet st e dr e fis a f uu lr tt eh de r o t no io tsu r l ole at nt e or b D lt i. g a1 t6 i/ o0 ns2 / t2 o0 2 B6 a na kn d o ft o B i an rf oo dr am y ano du t Bh aa nt k M a ofn g Ma al ha arm a D sr hu tg rs a a fn od r O ar g pa en ri ic os d exceeding 30 days, as per the regulations of your exchange. Sr.No Loan Account Name of Bank A Rm so .Iu nn t L aO cv se ar sd ou ne | Date D eo ff a s ut la tr t of Number - Cash 14/09/2026 21 060 4Cr 3 1e 8 7d 3 0i 5 5t 6 0A 1 0/ 2 0c. 4 6 0N 2o 4. B Ba an nk o of M Ba ah ra or da as htra 9 65 01 6. .1 09 1 27 0/ /1 10 0/ /2 20 02 25 5 Kindly acknowledge the same. Thanking You, For Mangalam Drugs and Organics Ltd., JeevarrDalvi Chief Financial Officer. Factory : at Vapi (Gujarat) India ® contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com